Skip to main content
DAEWON PHARMACEUTICAL CO.,LTD logo

DAEWON PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 003220 ISIN · KR7003220001 KO Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2021-02-03 Director's Dealing
Country KR South Korea
Listing KO 003220

About DAEWON PHARMACEUTICAL CO.,LTD

https://www.daewonpharm.com/eng

Daewon Pharmaceutical Co., Ltd., established in 1958, is a pharmaceutical company focused on improving human health. The company specializes in the development and manufacturing of prescription drugs and finished pharmaceutical products. Its portfolio includes a range of medications such as antipyretics, analgesics, and treatments for respiratory and cardiovascular conditions. Daewon Pharmaceutical maintains a strong commitment to research and development, with a strategic focus on New Chemical Entities (NCE) and Incrementally Modified Drugs (IMD) to provide advanced healthcare solutions.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders to disclose their personal share transactions. According to the provided filing categories, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2021-02-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard South Korean regulatory disclosure (often referred to as an 'Insider Trading Report' or 'Director's Dealing') where an executive or major shareholder reports their holdings or changes in holdings of the company's stock. Based on the provided categories, this fits the 'Director's Dealing' (DIRS) classification, which covers personal share transactions and ownership reports by company directors and executives.
2021-01-18 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Daewon Pharmaceutical Co., Ltd. covering the period from January 1, 2020, to September 30, 2020. It contains comprehensive financial information, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (South Korea). This type of filing is a standard regulatory requirement for insiders (directors/executives) to disclose their personal share transactions (buying or selling of company stock). According to the provided definitions, this falls under 'Director's Dealing' (DIRS).
2020-11-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service regarding their stake in Daewon Pharmaceutical. This type of filing is a regulatory requirement for entities that cross a 5% ownership threshold or experience significant changes in their holdings. In the context of financial reporting classifications, this falls under 'Major Shareholding Notification' (MRQ), which tracks changes in significant ownership levels.
2020-10-06 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the resignation of an outside director. It specifically details the 'appointment, dismissal, or mid-term resignation of an outside director'. This falls under the category of board and management changes.
2020-09-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.